Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Bordenave · SciRah

Researcher profile · Semantic Scholar

S. Bordenave

Share profile

S. Bordenave — researcher profile on SciRah

h-index: 11
Works: 20
Citations: 549

Most-cited papers

Antiproliferative activity of fish protein hydrolysates on human breast cancer cell lines
L. Picot, S. Bordenave, Sandrine Didelot, I. Fruitier-Arnaudin +6 more
2006236 citations
Semantic Scholar
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817
N. Ready, C. Audigier-Valette, J. Goldman, E. Felip +24 more
2023Journal for ImmunoTherapy of Cancer61 citations Open access
Semantic Scholar
Comparative effects of angiotensin IV and two hemorphins on angiotensin-converting enzyme activity.
I. Fruitier-Arnaudin, M. Cohen, S. Bordenave, F. Sannier +1 more
2002Peptides43 citations
Semantic Scholar
Family of Bioactive Heparin-Coated Iron Oxide Nanoparticles with Positive Contrast in Magnetic Resonance Imaging for Specific Biomedical Applications.
H. Groult, Nicolas Poupard, F. Herranz, E. Conforto +7 more
2017Biomacromolecules37 citations
Semantic Scholar
HPLC PREPARATION OF FISH WASTE HYDROLYSATE FRACTIONS. EFFECT ON GUINEA PIG ILEUM AND ACE ACTIVITY
S. Bordenave, I. Fruitier, Isabelle Ballandier, F. Sannier +3 more
2002Preparative Biochemistry & Biotechnology37 citations
Semantic Scholar
Continuous hydrolysis of goat whey in an ultrafiltration reactor: generation of alpha-lactorphin.
S. Bordenave, F. Sannier, G. Ricart, J. Piot
1999Preparative Biochemistry & Biotechnology30 citations
Semantic Scholar
Purification of goat beta-lactoglobulin from whey by an ultrafiltration membrane enzymic reactor.
Frédéric Sannier, S. Bordenave, J. Piot
2000Journal of Dairy Research28 citations
Semantic Scholar
‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’
J. Bennouna, H. Perrier, B. Paillot, F. Priou +9 more
2005British Journal of Cancer20 citations Open access
Semantic Scholar
Reduced level of opioid peptides, hemorphin-7 peptides, in serum of diabetic patients.
Ingrid I Fruiter-Arnaudin, M. Cohen, S. Nervi, S. Bordenave +2 more
2003Diabetes Care16 citations Open access
Semantic Scholar
Risk Factors of Venous Thromboembolic Disease in Cancer Patients Treated with Immune Checkpoint Inhibitor
Julien Denis le Sève, A. F. Guedon, S. Bordenave, C. Agard +4 more
2023Thrombosis and Haemostasis14 citations
Semantic Scholar
First description of French V. tubiashii strains pathogenic to mollusk: II. Characterization of properties of the proteolytic fraction of extracellular products.
R. Mersni-Achour, N. Imbert-Auvray, V. Huet, Y. Ben Cheikh +7 more
2014Journal of Invertebrate Pathology14 citations Open access
Semantic Scholar
First-line (1L) nivolumab (N) + ipilimumab (I) + chemotherapy (C) vs C alone in patients (pts) with metastatic NSCLC (mNSCLC) from CheckMate 9LA: 4-y clinical update and outcomes by tumor histologic subtype (THS).
D. Carbone, T. Ciuleanu, M. Schenker, M. Cobo-Dols +16 more
2023Journal of Clinical Oncology8 citations Open access
Semantic Scholar
292 Tegafox, a new combination of UFT/LV and oxaliplatin as first line treatment for patients (pts) with non resectable metastatic colorectal cancer (CRC): results of a completed multicenter phase II
J. Bennouna, H. Perrier, B. Paillot, J. Priou +6 more
20035 citations
Semantic Scholar
Phase II trial of extrapleural pneumonectomy followed by adjuvant radiotherapy in malignant pleural mesothelioma.
C. Peigaud, L. Cellerin, J. Roussel, C. Sagan +6 more
2009Journal of Clinical Oncology1 citations
Semantic Scholar
Modalities of biosimilar filgrastim use in clinical practice in > 1000 patients receiving chemotherapy regimens with a rest period of ≤ 14 days: The TOPAZE study
J. Phelip, P. Souquet, S. Bordenave, M. Declerck +2 more
2019Annals of Oncology0 citations Open access
Semantic Scholar
EGFR mutation detection in plasma of lung tumor patients to predict success in treatment with tyrosine kinase inhibitors in a routine clinical setting.
M. Denis, S. Hiret, S. Bordenave, A. Chiappa +16 more
20160 citations
Semantic Scholar
1581 Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: A multicentric observational national French study in patients with solid tumors (The Zohé study)
J. Eymard, A. Radji, R. Diab, S. Bordenave +5 more
20150 citations
Semantic Scholar
Short communication Antiproliferative activity of fish protein hydrolysates on human breast cancer cell lines
L. Picot, S. Bordenave, Sandrine Didelot, I. Fruitier-Arnaudin +3 more
20060 citations
Semantic Scholar
Crassostrea gigas peptic hydrolysate: a source of various biologically active molecules
S. Bordenave, I. Arnaudin, F. Sannier, J. Piot
20030 citations
Semantic Scholar
New systemic therapy for breast cancer
P. Fumoleau, D. Berton-Rigaud, V. Delecroix, F. Priou +1 more
1999Breast Cancer0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Sannier×8
Invite
F. Sannier — researcher profile on SciRah
J. Piot×8
Invite
J. Piot — researcher profile on SciRah
I. Fruitier-Arnaudin×5
Invite
I. Fruitier-Arnaudin — researcher profile on SciRah
J. Bennouna×3
Invite
J. Bennouna — researcher profile on SciRah

×2

Invite

L. Picot — researcher profile on SciRah

Sandrine Didelot×2

Invite

Sandrine Didelot — researcher profile on SciRah

G. Thorkelsson×2

Invite

G. Thorkelsson — researcher profile on SciRah

Invite

A. Chabeaud — researcher profile on SciRah

C. Audigier-Valette×2

Invite

C. Audigier-Valette — researcher profile on SciRah

Invite

T. Ciuleanu — researcher profile on SciRah

Ó. Juan-Vidal×2

Invite

Ó. Juan-Vidal — researcher profile on SciRah

Invite

L. Paz-Ares — researcher profile on SciRah